Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Hair cortisol concentrations in chronic central serous chorioretinopathy.

van Haalen FM, van Dijk EHC, Savas M, Brinks J, Dekkers OM, Dijkman G, van Rossum EFC, Biermasz NR, Boon CJF, Pereira AM.

Acta Ophthalmol. 2019 Oct 13. doi: 10.1111/aos.14269. [Epub ahead of print]

PMID:
31608607
2.

Complement Factor H Gene Mutations: Implications for Genetic Testing and Precision Medicine in Macular Degeneration.

den Hollander AI, Hoyng CB, Boon CJF.

Ophthalmology. 2019 Oct;126(10):1422-1423. doi: 10.1016/j.ophtha.2019.04.033. No abstract available.

PMID:
31543111
3.

Application of artificial intelligence (AI) in Radiotherapy workflow: Paradigm shift in Precision Radiotherapy using Machine Learning.

Boon IS, Au Yong TPT, Boon CS.

Br J Radiol. 2019 Sep 20:20190716. doi: 10.1259/bjr.20190716. [Epub ahead of print] No abstract available.

PMID:
31538513
4.

Long-Term Follow-Up of Retinal Degenerations Associated With LRAT Mutations and Their Comparability to Phenotypes Associated With RPE65 Mutations.

Talib M, van Schooneveld MJ, van Duuren RJG, Van Cauwenbergh C, Ten Brink JB, De Baere E, Florijn RJ, Schalij-Delfos NE, Leroy BP, Bergen AA, Boon CJF.

Transl Vis Sci Technol. 2019 Aug 19;8(4):24. doi: 10.1167/tvst.8.4.24. eCollection 2019 Jul.

5.

Foveal Sparing in Central Retinal Dystrophies.

Bax NM, Valkenburg D, Lambertus S, Klevering BJ, Boon CJF, Holz FG, Cremers FPM, Fleckenstein M, Hoyng CB, Lindner M; for the Foveal Sparing Atrophy Study Team (FAST).

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3456-3467. doi: 10.1167/iovs.18-26533.

PMID:
31398255
6.

Elevated Steroid Hormone Levels in Active Chronic Central Serous Chorioretinopathy.

Schellevis RL, Altay L, Kalisingh A, Mulders TWF, Sitnilska V, Hoyng CB, Boon CJF, Groenewoud JMM, de Jong EK, den Hollander AI.

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3407-3413. doi: 10.1167/iovs.19-26781.

PMID:
31387112
7.

Central serous chorioretinopathy: Towards an evidence-based treatment guideline.

van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ, Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF.

Prog Retin Eye Res. 2019 Jul 15. pii: S1350-9462(18)30094-6. doi: 10.1016/j.preteyeres.2019.07.003. [Epub ahead of print] Review.

8.

Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.

van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, MacLaren RE, Querques G, Fauser S, Hoyng CB, Downes SM, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1419-1425. doi: 10.1007/s00417-019-04333-y. Epub 2019 May 23.

PMID:
31123815
9.

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy.

Hanumunthadu D, van Dijk EHC, Dumpala S, Rajesh B, Jabeen A, Jabeen A, Ansari M, Mehta P, Shah S, Sarvaiya C, Meyerle C, Wu L, Banker A, Boon CJ, Chhablani J.

J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):164-170. doi: 10.4103/jovr.jovr_152_17.

10.

The ocular phenotype in primary hyperoxaluria type 1.

Birtel J, Herrmann P, Garrelfs SF, Dulz S, Atiskova Y, Diederen RM, Gliem M, Brinkert F, Holz FG, Boon CJF, Hoppe B, Charbel Issa P.

Am J Ophthalmol. 2019 May 10. pii: S0002-9394(19)30218-1. doi: 10.1016/j.ajo.2019.04.036. [Epub ahead of print]

PMID:
31078535
11.

Exome sequencing in patients with chronic central serous chorioretinopathy.

Schellevis RL, Breukink MB, Gilissen C, Boon CJF, Hoyng CB, de Jong EK, den Hollander AI.

Sci Rep. 2019 Apr 29;9(1):6598. doi: 10.1038/s41598-019-43152-3.

12.

Human iPSC-Derived Retinas Recapitulate the Fetal CRB1 CRB2 Complex Formation and Demonstrate that Photoreceptors and M├╝ller Glia Are Targets of AAV5.

Quinn PM, Buck TM, Mulder AA, Ohonin C, Alves CH, Vos RM, Bialecka M, van Herwaarden T, van Dijk EHC, Talib M, Freund C, Mikkers HMM, Hoeben RC, Goumans MJ, Boon CJF, Koster AJ, Chuva de Sousa Lopes SM, Jost CR, Wijnholds J.

Stem Cell Reports. 2019 May 14;12(5):906-919. doi: 10.1016/j.stemcr.2019.03.002. Epub 2019 Apr 4.

13.

Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.

van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF.

Am J Ophthalmol. 2019 Sep;205:1-10. doi: 10.1016/j.ajo.2019.03.025. Epub 2019 Apr 3.

PMID:
30951686
14.

Macular Dystrophy and Cone-Rod Dystrophy Caused by Mutations in the RP1 Gene: Extending the RP1 Disease Spectrum.

Verbakel SK, van Huet RAC, den Hollander AI, Geerlings MJ, Kersten E, Klevering BJ, Klaver CCW, Plomp AS, Wesseling NL, Bergen AAB, Nikopoulos K, Rivolta C, Ikeda Y, Sonoda KH, Wada Y, Boon CJF, Nakazawa T, Hoyng CB, Nishiguchi KM.

Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1192-1203. doi: 10.1167/iovs.18-26084.

PMID:
30913292
15.

Reply.

van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF.

Ophthalmology. 2019 Apr;126(4):e30-e31. doi: 10.1016/j.ophtha.2018.11.005. No abstract available.

PMID:
30910048
16.

Diagnosis and treatment of C3 glomerulopathy in a center of expertise.

Koopman JJE, Teng YKO, Boon CJF, van den Heuvel LP, Rabelink TJ, van Kooten C, de Vries APJ.

Neth J Med. 2019 Jan;77(1):10-18.

17.

Exome sequencing in families with chronic central serous chorioretinopathy.

Schellevis RL, van Dijk EHC, Breukink MB, Keunen JEE, Santen GWE, Hoyng CB, de Jong EK, Boon CJF, den Hollander AI.

Mol Genet Genomic Med. 2019 Apr;7(4):e00576. doi: 10.1002/mgg3.576. Epub 2019 Feb 6.

18.

On the origin of proteins in human drusen: The meet, greet and stick hypothesis.

Bergen AA, Arya S, Koster C, Pilgrim MG, Wiatrek-Moumoulidis D, van der Spek PJ, Hauck SM, Boon CJF, Emri E, Stewart AJ, Lengyel I.

Prog Retin Eye Res. 2019 May;70:55-84. doi: 10.1016/j.preteyeres.2018.12.003. Epub 2018 Dec 17. Review.

PMID:
30572124
19.

Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation.

Boon IS, Au Yong TPT, Boon CS.

Medicines (Basel). 2018 Dec 11;5(4). pii: E131. doi: 10.3390/medicines5040131. Review.

20.

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy.

Mohabati D, van Dijk EH, van Rijssen TJ, de Jong EK, Breukink MB, Martinez-Ciriano JP, Dijkman G, Hoyng CB, Fauser S, Yzer S, Boon CJ.

Clin Ophthalmol. 2018 Oct 24;12:2167-2176. doi: 10.2147/OPTH.S174573. eCollection 2018.

21.

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy.

Brinks J, van Dijk EHC, Habeeb M, Nikolaou A, Tsonaka R, Peters HAB, Sips HCM, van de Merbel AF, de Jong EK, Notenboom RGE, Kielbasa SM, van der Maarel SM, Quax PHA, Meijer OC, Boon CJF.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5682-5692. doi: 10.1167/iovs.18-25054.

PMID:
30489628
22.

Reply.

van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Keunen JEE, Groenewoud JMM, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF.

Ophthalmology. 2019 Jan;126(1):e11. doi: 10.1016/j.ophtha.2018.06.038. Epub 2018 Nov 22. No abstract available.

PMID:
30470545
23.

Management of central serous chorioretinopathy: Expert panel discussion.

Chhablani J, Anantharaman G, Behar-Cohen F, Boon C, Manayath G, Singh R.

Indian J Ophthalmol. 2018 Dec;66(12):1700-1703. doi: 10.4103/ijo.IJO_1411_18. Review.

24.

Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy.

van Haalen FM, van Dijk EHC, Andela CD, Dijkman G, Biermasz NR, Pereira AM, Boon CJF.

Acta Ophthalmol. 2019 Jun;97(4):e572-e579. doi: 10.1111/aos.13952. Epub 2018 Oct 30.

PMID:
30378259
25.

GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.

Mohabati D, Schellevis RL, van Dijk EHC, Altay L, Fauser S, Hoyng CB, De Jong EK, Boon CJF, Yzer S.

Retina. 2018 Oct 8. doi: 10.1097/IAE.0000000000002333. [Epub ahead of print]

PMID:
30300269
26.

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy.

van Rijssen TJ, Mohabati D, Dijkman G, Theelen T, de Jong EK, van Dijk EHC, Boon CJF.

PLoS One. 2018 Aug 24;13(8):e0202549. doi: 10.1371/journal.pone.0202549. eCollection 2018.

27.

The Spectrum of Structural and Functional Abnormalities in Female Carriers of Pathogenic Variants in the RPGR Gene.

Talib M, van Schooneveld MJ, Van Cauwenbergh C, Wijnholds J, Ten Brink JB, Florijn RJ, Schalij-Delfos NE, Dagnelie G, van Genderen MM, De Baere E, Meester-Smoor MA, De Zaeytijd J, Cremers FPM, van den Born LI, Thiadens AA, Hoyng CB, Klaver CC, Leroy BP, Bergen AA, Boon CJF.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4123-4133. doi: 10.1167/iovs.17-23453.

PMID:
30105367
28.

Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.

Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK.

JAMA Ophthalmol. 2018 Oct 1;136(10):1128-1136. doi: 10.1001/jamaophthalmol.2018.3190.

29.

Discrepancy in current central serous chorioretinopathy classification.

Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.

Br J Ophthalmol. 2019 Jun;103(6):737-742. doi: 10.1136/bjophthalmol-2018-312435. Epub 2018 Jul 12.

PMID:
30002069
30.

Gender variation in central serous chorioretinopathy.

Hanumunthadu D, Van Dijk EHC, Gangakhedkar S, Goud A, Cheung CMG, Cherfan D, Sarvaiya C, Banker A, Meyerle C, Boon CJ, Singh R, Wu L, Chhablani J.

Eye (Lond). 2018 Nov;32(11):1703-1709. doi: 10.1038/s41433-018-0163-7. Epub 2018 Jul 9.

PMID:
29988073
31.

The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe Variants.

Runhart EH, Sangermano R, Cornelis SS, Verheij JBGM, Plomp AS, Boon CJF, Lugtenberg D, Roosing S, Bax NM, Blokland EAW, Jacobs-Camps MHM, van der Velde-Visser SD, Pott JR, Rohrschneider K, Thiadens AAHJ, Klaver CCW, van den Born LI, Hoyng CB, Cremers FPM.

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3220-3231. doi: 10.1167/iovs.18-23881.

PMID:
29971439
32.

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy.

Mohabati D, van Rijssen TJ, van Dijk EH, Luyten GP, Missotten TO, Hoyng CB, Yzer S, Boon CJ.

Clin Ophthalmol. 2018 Jun 7;12:1061-1070. doi: 10.2147/OPTH.S160956. eCollection 2018.

33.

Bilateral peritonsillar abscess: A rare emergency.

Boon C, Wan Mohamad WE, Mohamad I.

Malays Fam Physician. 2018 Apr 30;13(1):41-44. eCollection 2018.

34.

Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial.

van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF.

Ophthalmology. 2018 Oct;125(10):1547-1555. doi: 10.1016/j.ophtha.2018.04.021. Epub 2018 Jun 14.

35.

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.

van Rijssen TJ, van Dijk EHC, Dijkman G, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1395-1402. doi: 10.1007/s00417-018-4003-z. Epub 2018 May 7.

36.

Special Issue Introduction: Inherited Retinal Disease: Novel Candidate Genes, Genotype-Phenotype Correlations, and Inheritance Models.

Cremers FPM, Boon CJF, Bujakowska K, Zeitz C.

Genes (Basel). 2018 Apr 16;9(4). pii: E215. doi: 10.3390/genes9040215.

37.

Non-syndromic retinitis pigmentosa.

Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, Hoyng CB, Roepman R, Klevering BJ.

Prog Retin Eye Res. 2018 Sep;66:157-186. doi: 10.1016/j.preteyeres.2018.03.005. Epub 2018 Mar 27. Review.

38.

CLINICAL AND GENETIC CHARACTERISTICS OF MALE PATIENTS WITH RPGR-ASSOCIATED RETINAL DYSTROPHIES: A Long-Term Follow-up Study.

Talib M, van Schooneveld MJ, Thiadens AA, Fiocco M, Wijnholds J, Florijn RJ, Schalij-Delfos NE, van Genderen MM, Putter H, Cremers FPM, Dagnelie G, Ten Brink JB, Klaver CCW, van den Born LI, Hoyng CB, Bergen AA, Boon CJF.

Retina. 2019 Jun;39(6):1186-1199. doi: 10.1097/IAE.0000000000002125.

PMID:
29528978
39.

Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.

van Haalen FM, van Dijk EHC, Dekkers OM, Bizino MB, Dijkman G, Biermasz NR, Boon CJF, Pereira AM.

Front Endocrinol (Lausanne). 2018 Feb 20;9:39. doi: 10.3389/fendo.2018.00039. eCollection 2018.

40.

Pimasertib-associated ophthalmological adverse events.

van Dijk EHC, Kruit WHJ, Jager MJ, Luyten GPM, Vingerling JR, Boon CJF.

Acta Ophthalmol. 2018 Nov;96(7):712-718. doi: 10.1111/aos.13677. Epub 2018 Jan 16.

PMID:
29338133
41.

FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY.

van Dijk EHC, Schellevis RL, Breukink MB, Mohabati D, Dijkman G, Keunen JEE, Yzer S, den Hollander AI, Hoyng CB, de Jong EK, Boon CJF.

Retina. 2019 Feb;39(2):398-407. doi: 10.1097/IAE.0000000000001966.

PMID:
29190234
42.

Measuring Central Retinal Sensitivity Using Microperimetry.

Talib M, Jolly JK, Boon CJF.

Methods Mol Biol. 2018;1715:339-349. doi: 10.1007/978-1-4939-7522-8_25.

PMID:
29188526
43.

Recording and Analysis of Goldmann Kinetic Visual Fields.

Talib M, Dagnelie G, Boon CJF.

Methods Mol Biol. 2018;1715:327-338. doi: 10.1007/978-1-4939-7522-8_24.

PMID:
29188525
44.

AAV Serotype Testing on Cultured Human Donor Retinal Explants.

Buck TM, Pellissier LP, Vos RM, van Dijk EHC, Boon CJF, Wijnholds J.

Methods Mol Biol. 2018;1715:275-288. doi: 10.1007/978-1-4939-7522-8_20.

PMID:
29188521
45.

Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.

van Dijk EHC, Soonawala D, Rooth V, Hoyng CB, Meijer OC, de Vries APJ, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2443-2449. doi: 10.1007/s00417-017-3823-6. Epub 2017 Oct 23.

46.

LONG-TERM FOLLOW-UP OF PATIENTS WITH CHOROIDEREMIA WITH SCLERAL PITS AND TUNNELS AS A NOVEL OBSERVATION.

van Schuppen SM, Talib M, Bergen AA, Ten Brink JB, Florijn RJ, Boon CJF, van Schooneveld MJ.

Retina. 2018 Sep;38(9):1713-1724. doi: 10.1097/IAE.0000000000001844.

PMID:
28937528
47.

Osm1 facilitates the transfer of electrons from Erv1 to fumarate in the redox-regulated import pathway in the mitochondrial intermembrane space.

Neal SE, Dabir DV, Wijaya J, Boon C, Koehler CM.

Mol Biol Cell. 2017 Oct 15;28(21):2773-2785. doi: 10.1091/mbc.E16-10-0712. Epub 2017 Aug 16.

48.

MAINTENANCE OF GOOD VISUAL ACUITY IN BEST DISEASE ASSOCIATED WITH CHRONIC BILATERAL SEROUS MACULAR DETACHMENT.

Gattoussi S, Boon CJF, Freund KB.

Retin Cases Brief Rep. 2017 Aug 10. doi: 10.1097/ICB.0000000000000618. [Epub ahead of print]

PMID:
28806213
49.

Outcome of Full-Thickness Macular Hole Surgery in Choroideremia.

Talib M, Koetsier LS, MacLaren RE, Boon CJF.

Genes (Basel). 2017 Jul 21;8(7). pii: E187. doi: 10.3390/genes8070187.

50.

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.

van Dijk EHC, Dijkman G, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2029-2035. doi: 10.1007/s00417-017-3720-z. Epub 2017 Jul 3.

Supplemental Content

Support Center